Literature DB >> 11114697

The potent role of increased sympathetic tone in pathogenesis of essential hypertension with neurovascular compression.

T Morise1, M Horita, I Kitagawa, R Shinzato, Y Hoshiba, H Masuya, M Suzuki, N Takekoshi.   

Abstract

OBJECTIVE: To study the role of increased sympathetic tone in pathogenesis of hypertension in patients with essential hypertension with neurovascular compression.
METHODS: Twenty-three patients with essential hypertension, 13 patients with secondary hypertension, and 46 normotensive subjects were investigated. Neurovascular compression was evaluated by MRT. The power spectral components of heart rate variability as indices of autonomic nerve tone were determined to investigate the possibility that sympathetic tone mediates the neurovascular compression-induced increase in blood pressure.
RESULTS: Neurovascular compression of the rostral ventrolateral medulla (RVLM) was observed in 70% of essential hypertension group, none of secondary hyperension group and 16% of normotensive group (P < 0.001). The age-adjusted low-frequency power spectral density (A-PSD) (0.04 to 0.15 Hz), which is an index of sympathetic tone, was significantly higher in patients with essential hypertension (139.5 +/- 6.7%) with neurovascular compression than in essential hypertension patients without neurovascular compression (92.2 +/- 6.8%), normotensive subjects with (102.8 +/- 13.0%) and without neurovascular compression (100.1 +/- 4.1%), and patients with secondary hypertension (95.7 +/- 10.2%) (P < 0.001). There was no significant difference in the high-frequency A-PSD (0.15 to 0.40 Hz), which is an index of vagal tone, among groups.
CONCLUSIONS: Neurovascular compression was not always associated with an increase in sympathetic nerve tone. Hypertension was present in subjects with neurovascular compression, who had increased sympathetic tone but not in those with normal sympathetic tone. An increase in sympathetic tone may mediate the neurovascular compression-induced increase in blood pressure. Journal of Human Hypertension (2000) 14, 807-811

Entities:  

Mesh:

Year:  2000        PMID: 11114697     DOI: 10.1038/sj.jhh.1001114

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  6 in total

1.  c-Src in paraventricular nucleus modulates sympathetic activity and cardiac sympathetic afferent reflex in renovascular hypertensive rats.

Authors:  Ying Han; Ning Yuan; Shu-Juan Zhang; Juan Gao; Zhen Shi; Ye-Bo Zhou; Xing-Ya Gao; Guo-Qing Zhu
Journal:  Pflugers Arch       Date:  2011-02-22       Impact factor: 3.657

2.  The spectrum of magnetic resonance imaging findings in hypertension-related neurovascular compression.

Authors:  Mauricio Michalak Sendeski; Fernanda Marciano Consolim-Colombo; Eduardo Moacyr Krieger; Cláudia da Costa Leite
Journal:  Neuroradiology       Date:  2005-12-06       Impact factor: 2.804

Review 3.  The evolving roles of alarin in physiological and disease conditions, and its future potential clinical implications.

Authors:  Endeshaw Chekol Abebe; Misganaw Asmamaw Mengstie; Mohammed Abdu Seid; Tabarak Malik; Tadesse Asmamaw Dejenie
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-29       Impact factor: 6.055

Review 4.  Neurovascular compression of the medulla: can it cause neurogenic hypertension?

Authors:  Thomas G Pickering
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-01       Impact factor: 3.738

5.  Angiotensin-(1-7) in paraventricular nucleus modulates sympathetic activity and cardiac sympathetic afferent reflex in renovascular hypertensive rats.

Authors:  Ying Han; Hai-Jian Sun; Peng Li; Qing Gao; Ye-bo Zhou; Feng Zhang; Xing-Ya Gao; Guo-Qing Zhu
Journal:  PLoS One       Date:  2012-11-05       Impact factor: 3.240

6.  Angiotensin II and angiotensin-(1-7) in paraventricular nucleus modulate cardiac sympathetic afferent reflex in renovascular hypertensive rats.

Authors:  Hai-Jian Sun; Peng Li; Wei-Wei Chen; Xiao-Qing Xiong; Ying Han
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.